Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 01/08/19941 min de leitura
Conference on Feasibility of Genetic Technology to Close the HIV Window in Donor Screening; Notice of Public Meeting
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA), Office of the Commissioner, is sponsoring a public meeting to evaluate the feasibility and utility of gene amplification techniques to enhance viral detection in the seronegative ``window'' phase of human immunodeficiency virus (HIV) infection. DATES: The public meeting will be held on Monday, September 26, 1994, 7 a.m. to 4 p.m. through Wednesday, September 28, l994, 12 m.
Idioma original da fonte: Federal Register — Health and Human ServicesAbrir o comunicado original →